| Universal Influenza A Vaccine in Healthy Adults (NCT05155319) | Emergent BioSolutions | 2021-12-01 |
| Tfh Dysfunction in HIV and Aging (NCT04487041) | University of Miami | 2020-10-30 |
| Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens (NCT04431050) | Imperial College London | 2020-02-21 |
| Safety of 4Fluart ID Suspension for Injection in Adult Subjects (NCT03448705) | Fluart Innovative Vaccine Ltd, Hungary | 2018-01-31 |
| Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine (NCT03572491) | Research Institute for Biological Safety Problems | 2017-09-18 |
| Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting (NCT02478905) | University of Zurich | 2016-01-01 |
| Post-Marketing Observational Study of Safety Following Vaccination With Flublok® Compared to Licensed IIV in Adults (NCT02600585) | Protein Sciences Corporation | 2015-11-01 |
| A Study to Evaluate Safety and Immunogenicity of Trivalent Influenza Vaccine, Formulation 2015 Southern Hemisphere, When Administered to Healthy Adult Subjects. (NCT02427750) | Novartis | 2015-04-01 |
| Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents (NCT02387294) | Fluart Innovative Vaccine Ltd, Hungary | 2014-10-01 |
| Clinical Trial for the Evaluation of Three Regimens of Influenza Vaccination in Kidney Transplant Recipients (NCT02104869) | Butantan Institute | 2014-04-01 |
| Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above (NCT01885117) | Novartis Vaccines | 2013-08-01 |
| Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, Including MF59C.1 Adjuvant, in Healthy Adults ≥65 Years of Age (NCT01879540) | Novartis Vaccines | 2013-07-01 |
| Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above (NCT01879553) | Novartis Vaccines | 2013-07-01 |
| Panama and El Salvador Children's Oseltamivir Study (NCT01690637) | Centers for Disease Control and Prevention | 2012-09-01 |
| Safety and Immunogenicity of a Subunit Trivalent Nonadjuvated Influenza Study Vaccine in Adults Aged 18 Years and Above (NCT01636102) | Novartis Vaccines | 2012-07-01 |
| Safety and Immunogenicity of a Trivalent Influenza Vaccine When Administered to Elderly Subjects (NCT01651104) | Novartis Vaccines | 2012-07-01 |
| Conventional Vaccine and Intradermal Vaccine Among HIV-infected Young Subjects (NCT02398097) | Korea University Guro Hospital | 2011-11-01 |
| Phase IV Clinical Trial of an Inactivated Influenza Split Vaccine (NCT01511744) | Hualan Biological Engineering, Inc. | 2011-11-01 |
| Study of Yili Mei Yi Tian Active Lactobacillus Drink to Improve Immunity and Digestive System (NCT01677715) | Inner Mongolia Yili Industrial Group Co., Ltd | 2011-08-01 |
| Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects (NCT01342796) | Novartis Vaccines | 2011-05-01 |
| Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization (NCT01677702) | Inner Mongolia Yili Industrial Group Co., Ltd | 2011-03-01 |
| Immunogenicity Study of S-OIV H1N1 Influenza Vaccine (NCT01096225) | Chinese Academy of Sciences | 2010-03-01 |
| Bangladesh Secondary Transmission Handwashing Protocol (NCT00880659) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2009-06-01 |
| Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza. (NCT04682444) | Joint Stock Company "Farmak" | 2009-04-13 |